Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Advances in Pharmacology (San Diego, Calif.)
|
February 26, 2013
The biology of thymic stromal lymphopoietin (TSLP)
Steven F Ziegler, Florence Roan, Bryan D Bell, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 17, 2009
[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel]
Masayuki Kitajima, Go Satoh, Takashi Marusasa, et al.
International Journal of Cancer
|
January 21, 2006
Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Anti-Cancer Drugs
|
March 22, 2006
Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1
Yuko Tsuruoka, Toshiki Kamano, Masayuki Kitajima, et al.
Plos One
|
June 21, 2013
Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis
Akihiro Hasegawa, Chiaki Iwamura, Masayuki Kitajima, et al.
Anti-Cancer Drugs
|
December 13, 2006
Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Clinical Immunology (Orlando, Fla.)
|
March 15, 2011
Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses
Yoshiro Hirasaki, Chiaki Iwamura, Masakatsu Yamashita, et al.
Experimental and Therapeutic Medicine
|
September 21, 2012
Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test
Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Molecular and Clinical Oncology
|
October 4, 2014
Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy
Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Journal of Surgical Oncology
|
June 22, 2006
Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Advances in Pharmacology (San Diego, Calif.)
|
February 26, 2013
The biology of thymic stromal lymphopoietin (TSLP)
Steven F Ziegler, Florence Roan, Bryan D Bell, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
September 17, 2009
[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel]
Masayuki Kitajima, Go Satoh, Takashi Marusasa, et al.
International Journal of Cancer
|
January 21, 2006
Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Anti-Cancer Drugs
|
March 22, 2006
Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1
Yuko Tsuruoka, Toshiki Kamano, Masayuki Kitajima, et al.
Plos One
|
June 21, 2013
Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis
Akihiro Hasegawa, Chiaki Iwamura, Masayuki Kitajima, et al.
Anti-Cancer Drugs
|
December 13, 2006
Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Clinical Immunology (Orlando, Fla.)
|
March 15, 2011
Repressor of GATA negatively regulates murine contact hypersensitivity through the inhibition of type-2 allergic responses
Yoshiro Hirasaki, Chiaki Iwamura, Masakatsu Yamashita, et al.
Experimental and Therapeutic Medicine
|
September 21, 2012
Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test
Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Molecular and Clinical Oncology
|
October 4, 2014
Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy
Takumi Ochiai, Kazuhiko Nishimura, Tomoo Watanabe, et al.
Journal of Surgical Oncology
|
June 22, 2006
Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy
Takumi Ochiai, Kazuhiko Nishimura, Hajime Noguchi, et al.
Page
of 5